{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:17:30Z","timestamp":1770506250280,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4-5","license":[{"start":{"date-parts":[[2006,12,21]],"date-time":"2006-12-21T00:00:00Z","timestamp":1166659200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2007,3,22]]},"DOI":"10.1007\/s11064-006-9222-8","type":"journal-article","created":{"date-parts":[[2006,12,20]],"date-time":"2006-12-20T22:59:25Z","timestamp":1166655565000},"page":"837-843","source":"Crossref","is-referenced-by-count":15,"title":["Some Observations upon Biochemical Causes of Ataxia and a New Disease Entity Ubiquinone, CoQ10 Deficiency"],"prefix":"10.1007","volume":"32","author":[{"given":"John M.","family":"Land","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon J. R.","family":"Heales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iain P.","family":"Hargreaves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,12,21]]},"reference":[{"key":"9222_CR1","unstructured":"Refsum\u2019s Heredopathia actica polyneuritiformis (1946) Acta Psychiatr Scand Suppl 38:9"},{"key":"9222_CR2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1515\/bchm2.1963.333.1.133","volume":"333","author":"E Klenk","year":"1963","unstructured":"Klenk E, Kahike W (1963) On the presence of 3,7,11,15-tetramethylhexadecanoic acid (phytanic acid) in the cholesterol esters and other fractions of the organs in a case of a disease of unknown origin (possibly heredopathia atactica polyneuritiformis, Refsum\u2019s syndrome). Hoppe Seylers Z Physiol Chem 333:133\u2013139","journal-title":"Hoppe Seylers Z Physiol Chem"},{"key":"9222_CR3","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/0006-291X(65)90328-1","volume":"19","author":"D Steinberg","year":"1965","unstructured":"Steinberg D, Avigan J, Mize C, Eldjarn L, Try K, Refsum S (1965) Conversion of U-C14-phytol to phytanic acid and its oxidation in heredopathia atactica polyneuritiformis. Biochem Biophys Res Commun 19:783\u2013789","journal-title":"Biochem Biophys Res Commun"},{"issue":"187","key":"9222_CR4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0005-2760(69)90130-1","volume":"29","author":"JP Blass","year":"1969","unstructured":"Blass JP, Avign J, Steinberg D (1969) Alpha-hydroxy fatty acids in hereditary ataxic polyneuritis (Refsum\u2019s disease). Biochim Biophys Acta 29(187):36\u201341","journal-title":"Biochim Biophys Acta"},{"key":"9222_CR5","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/S0021-9258(18)83452-4","volume":"244","author":"SC Tsai","year":"1969","unstructured":"Tsai SC, Avigan J, Steinberg D (1969) Studies on the alpha oxidation of phytanic acid by rat liver mitochondria. J Biol Chem 244:2682\u20132692","journal-title":"J Biol Chem"},{"key":"9222_CR6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0006-291X(67)90352-X","volume":"28","author":"SC Tsai","year":"1967","unstructured":"Tsai SC, Herndon JH Jr, Uhlendorf BW, Fales HM, Mize CE (1967) The formation of alpha-hydroxy phytanic acid from phytanic acid in mammalian tissues. Biochem Biophys Res Commun 28:571\u2013577","journal-title":"Biochem Biophys Res Commun"},{"key":"9222_CR7","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1172\/JCI106059","volume":"48","author":"CE Mize","year":"1969","unstructured":"Mize CE, Herndon JH Jr, Blass JP, Milne GW, Follansbee C, Laudat P, Steinberg D (1969) Localization of the oxidative defect in phytanic acid degradation in patients with Refsum\u2019s disease. J Clin Invest 48:1033\u20131040","journal-title":"J Clin Invest"},{"key":"9222_CR8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ng1097-190","volume":"17","author":"GA Jansen","year":"1997","unstructured":"Jansen GA, Ofman R, Ferdinandusse S, Ijlst L, Muijsers AO, Skjeldal OH, Stokke O, Jakobs C, Besley GTN, Wraith JE, Wanders RJA (1997) Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene. Nat Genet 17:190\u2013193","journal-title":"Nat Genet"},{"key":"9222_CR9","volume-title":"Inborn errors of metabolism","author":"AE Garrod","year":"1909","unstructured":"Garrod AE (1909) Inborn errors of metabolism Oxford University Press. England"},{"key":"9222_CR10","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0140-6736(66)91632-1","volume":"1","author":"L Eldjarn","year":"1966","unstructured":"Eldjarn L, Try K, Stokke O, et al (1966) Dietary effects on serum-phytanic-acid levels and on clinical manifestations in heredopathia atactica polyneuritiformis. Lancet 1:691\u2013693","journal-title":"Lancet"},{"key":"9222_CR11","first-page":"53","volume":"1","author":"RA Kark","year":"1971","unstructured":"Kark RA, Engel WK, Blass JP, et al (1971) Heredopathia actica polyneuritiformis (Refsum\u2019s Disease): a second trial of dietary therapy in two patients. Birth Defects Orig Artic Ser 1:53\u201355","journal-title":"Birth Defects Orig Artic Ser"},{"key":"9222_CR12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1212\/WNL.33.2.237","volume":"33","author":"G Djupesland","year":"1983","unstructured":"Djupesland G, Flottorp G, Refsum S (1983) Phytanic acid storage disease: hearing maintained after 15\u00a0years of dietary treatment. Neurology 33:237\u2013240","journal-title":"Neurology"},{"key":"9222_CR13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1172\/JCI106251","volume":"49","author":"JP Blass","year":"1970","unstructured":"Blass JP, Avigan J, Uhlendorf BW (1970) A defect in pyruvate decarboxylase in a child with an intermittent movement disorder. J Clin Invest 49:423\u2013432","journal-title":"J Clin Invest"},{"key":"9222_CR14","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S0140-6736(71)91822-8","volume":"7712","author":"JP Blass","year":"1971","unstructured":"Blass JP, Lonsdale D, Uhlendorf BW, Hom E (1971) Intermittent ataxia with pyruvate-decarboxylase deficiency. Lancet 7712:1302","journal-title":"Lancet"},{"key":"9222_CR15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/archneur.1971.00490050083007","volume":"25","author":"JP Blass","year":"1971","unstructured":"Blass JP, Kark AP, Engel WK (1971) Clinical studies of a patient with pyruvate decarboxylase deficiency. Arch Neurol 25:449\u2013460","journal-title":"Arch Neurol"},{"key":"9222_CR16","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1212\/WNL.26.7.625","volume":"26","author":"SF Reynolds","year":"1976","unstructured":"Reynolds SF, Blass J (1976) A possible mechanism for selective cerebellar damage in partial pyruvate dehydrogenase deficiency. Neurology 26:625\u2013628","journal-title":"Neurology"},{"key":"9222_CR17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1042\/bj3020171","volume":"302","author":"T Letellier","year":"1994","unstructured":"Letellier T, Heinrich R, Malgat M, Mazat JP (1994) The kinetic basis of threshold effects observed in mitochondrial diseases: a systemic approach. Biochem J 302:171\u2013174","journal-title":"Biochem J"},{"key":"9222_CR18","doi-asserted-by":"crossref","first-page":"12753","DOI":"10.1074\/jbc.273.21.12753","volume":"273","author":"GP Davey","year":"1998","unstructured":"Davey GP, Peuchen S, Clark JB (1998) Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration. J Biol Chem 273:12753\u201312757","journal-title":"J Biol Chem"},{"key":"9222_CR19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02834298","volume":"4","author":"JM Cedarbaum","year":"1986","unstructured":"Cedarbaum JM, Blass JP (1986) Mitochondrial dysfunction and spinocerebellar degenerations. Neurochem Pathol 4:43\u201363","journal-title":"Neurochem Pathol"},{"key":"9222_CR20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF01001015","volume":"3","author":"KF Sheu","year":"1988","unstructured":"Sheu KF, Blass JP, Cedarbaum JM, et al (1988) Mitochondrial enzymes in hereditary ataxias. Metab Brain Dis 3:151\u2013160","journal-title":"Metab Brain Dis"},{"key":"9222_CR21","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","volume":"271","author":"V Campuzano","year":"1996","unstructured":"Campuzano V, Montermini L, Molto MD, et al (1996) Friedreich\u2019s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271:1423\u20131427","journal-title":"Science"},{"key":"9222_CR22","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM199610173351601","volume":"335","author":"A Durr","year":"1996","unstructured":"Durr A, Cossee M, Agid Y, et al (1996) Clinical and genetic abnormalities in patients with Friedreich\u2019s ataxia. N Engl J Med 335:1169\u20131175","journal-title":"N Engl J Med"},{"key":"9222_CR23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0005-2728(98)00114-5","volume":"1366","author":"MF Beal","year":"1998","unstructured":"Beal MF (1998) Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1366:211\u2013223","journal-title":"Biochim Biophys Acta"},{"key":"9222_CR24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jns.2005.03.012","volume":"233","author":"V Calabrese","year":"2005","unstructured":"Calabrese V, Lodi R, Tonon C, et al (2005) Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich\u2019s ataxia. J Neurol Sci 233:145\u2013162","journal-title":"J Neurol Sci"},{"key":"9222_CR25","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/mds.1162","volume":"16","author":"M Pandolfo","year":"2001","unstructured":"Pandolfo M (2001) Molecular basis of Friedreich ataxia. Mov Disord 16:815\u2013821","journal-title":"Mov Disord"},{"key":"9222_CR26","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1212\/WNL.55.11.1752","volume":"55","author":"M Emond","year":"2000","unstructured":"Emond M, Lepage G, Vanasse M, Pandolfo M (2000) Increased levels of plasma malondialdehyde in Friedreich ataxia. Neurology 55:1752\u20131753","journal-title":"Neurology"},{"key":"9222_CR27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(99)01341-0","volume":"354","author":"P Rustin","year":"1999","unstructured":"Rustin P, von Kleist-Retzow JC, Chantrel-Groussard K, et al (1999) Effect of idebenone on cardiomyopathy in Friedreich\u2019s ataxia: a preliminary study. Lancet 354:477\u2013479","journal-title":"Lancet"},{"key":"9222_CR28","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1212\/01.WNL.0000134607.76780.B2","volume":"63","author":"K Aure","year":"2004","unstructured":"Aure K, Benoist JF, Ogier de Baulny H, Romero NB, Rigal O, Lombes A (2004) Progression despite replacement of a myopathic form of coenzyme Q10 defect. Neurology 63:727\u2013729","journal-title":"Neurology"},{"key":"9222_CR29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-2004-815830","volume":"35","author":"R Artuch","year":"2004","unstructured":"Artuch R, Aracil A, Mas A, et al (2004) Cerebrospinal fluid concentrations of idebenone in Friedreich ataxia patients. Neuropediatrics 35:95\u201398","journal-title":"Neuropediatrics"},{"key":"9222_CR30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jns.2006.01.021","volume":"246","author":"R Artuch","year":"2006","unstructured":"Artuch R, Brea-Calvo G, Briones P, et al (2006) Cerebellar ataxia with coenzyme Q10 deficiency: diagnosis and follow-up after coenzyme. J Neurol Sci 246:153\u2013158","journal-title":"J Neurol Sci"},{"key":"9222_CR31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bbamem.2003.11.012","volume":"1660","author":"M Turunen","year":"2004","unstructured":"Turunen M, Olsson J, Dallner G (2004) Metabolism and function of coenzyme Q. Biochim Biophys Acta 1660:171\u2013199","journal-title":"Biochim Biophys Acta"},{"key":"9222_CR32","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2174\/0929867033456882","volume":"10","author":"CW Shults","year":"2003","unstructured":"Shults CW (2003) Coenzyme Q10 in neurodegenerative diseases. Curr Med Chem 10:1917\u20131921","journal-title":"Curr Med Chem"},{"key":"9222_CR33","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.mito.2004.07.035","volume":"4","author":"AW Linnane","year":"2004","unstructured":"Linnane AW, Eastwood H (2004) Cellular redox poise modulation; the role of coenzyme Q10, gene and metabolic regulation. Mitochondrion 4:779\u2013789","journal-title":"Mitochondrion"},{"key":"9222_CR34","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1212\/WNL.57.3.515","volume":"57","author":"S Di Giovanni","year":"2001","unstructured":"Di Giovanni S, Mirabella M, Spinazzola A, et al (2001) Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency. Neurology 57:515\u2013518","journal-title":"Neurology"},{"key":"9222_CR35","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1517\/13543784.12.10.1655","volume":"12","author":"SK Baker","year":"2003","unstructured":"Baker SK, Tarnopolsky MA (2003) Targeting cellular energy production in neurological disorders. Expert Opin Investig Drugs 12:1655\u20131679","journal-title":"Expert Opin Investig Drugs"},{"key":"9222_CR36","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0021-9258(19)40172-5","volume":"265","author":"A Kalen","year":"1990","unstructured":"Kalen A, Appelkvist EL, Chojnacki T, Dallner G (1990) Nonaprenyl-4-hydroxybenzoate transferase, an enzyme involved in ubiquinone biosynthesis, in the endoplasmic reticulum-Golgi system of rat liver. J Biol Chem 265:1158\u20131164","journal-title":"J Biol Chem"},{"key":"9222_CR37","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1373\/clinchem.2005.054643","volume":"51","author":"AJ Duncan","year":"2005","unstructured":"Duncan AJ, Heales SJ, Mills K, Eaton S, Land JM, Hargreaves IP (2005) Determination of coenzyme Q10 status in blood mononuclear cells, skeletal muscle, and plasma by HPLC with di-propoxy-coenzyme Q10 as an internal standard. Clin Chem 51:2380\u20132382","journal-title":"Clin Chem"},{"key":"9222_CR38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0925-4439(95)00028-3","volume":"1271","author":"L Ernster","year":"1995","unstructured":"Ernster L, Dallner G (1995) Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta 1271:195\u2013204","journal-title":"Biochim Biophys Acta"},{"key":"9222_CR39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jns.2006.03.017","volume":"246","author":"M Hirano","year":"2006","unstructured":"Hirano M, Quinzii CM, Dimauro S (2006) Restoring balance to ataxia with coenzyme Q10 deficiency. J Neurol Sci 246:11\u201312","journal-title":"J Neurol Sci"},{"key":"9222_CR40","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/BF00441735","volume":"144","author":"JC Fischer","year":"1986","unstructured":"Fischer JC, Ruitenbeek W, Gabreels FJ, et al (1986) A mitochondrial encephalomyopathy: the first case with an established defect at the level of coenzyme Q. Eur J Pediatr 144:441\u2013444","journal-title":"Eur J Pediatr"},{"key":"9222_CR41","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1073\/pnas.86.7.2379","volume":"86","author":"S Ogasahara","year":"1989","unstructured":"Ogasahara S, Engel AG, Frens D, Mack D (1989) Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci USA 86:2379\u20132382","journal-title":"Proc Natl Acad Sci USA"},{"key":"9222_CR42","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1212\/01.WNL.0000055089.39373.FC","volume":"60","author":"C Lamperti","year":"2003","unstructured":"Lamperti C, Naini A, Hirano M, et al (2003) Cerebellar ataxia and coenzyme Q10 deficiency. Neurology 60:1206\u20131208","journal-title":"Neurology"},{"key":"9222_CR43","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/ana.10371","volume":"52","author":"L Maldergem Van","year":"2002","unstructured":"Van Maldergem L, Trijbels F, DiMauro S, et al (2002) Coenzyme Q-responsive Leigh\u2019s encephalopathy in two sisters. Ann Neurol 52:750\u2013754","journal-title":"Ann Neurol"},{"key":"9222_CR44","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0140-6736(00)02531-9","volume":"356","author":"A Rotig","year":"2000","unstructured":"Rotig A, Appelkvist EL, Geromel V, et al (2000) Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet 356:391\u2013395","journal-title":"Lancet"},{"key":"9222_CR45","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1067\/mpd.2001.117575","volume":"139","author":"S Rahman","year":"2001","unstructured":"Rahman S, Hargreaves I, Clayton P, Heales S (2001) Neonatal presentation of coenzyme Q10 deficiency. J Pediatr 139:456\u2013458","journal-title":"J Pediatr"},{"key":"9222_CR46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/01.wnl.0000194241.35115.7c","volume":"66","author":"R Horvath","year":"2006","unstructured":"Horvath R, Schneiderat P, Schoser BG, et al (2006) Coenzyme Q10 deficiency and isolated myopathy. Neurology 66:253\u2013255","journal-title":"Neurology"},{"key":"9222_CR47","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/archneur.62.2.317","volume":"62","author":"SR Lalani","year":"2005","unstructured":"Lalani SR, Vladutiu GD, Plunkett K, et al (2005) Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency. Arch Neurol 62:317\u2013320","journal-title":"Arch Neurol"},{"key":"9222_CR48","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/01.WNL.0000150588.75281.58","volume":"64","author":"CM Quinzii","year":"2005","unstructured":"Quinzii CM, Kattah AG, Naini a, et al (2005) Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. Neurology 64:539\u2013541","journal-title":"Neurology"},{"key":"9222_CR49","first-page":"151","volume-title":"In a practical approach to the investigation of metabolic disease","author":"JB Clark","year":"1996","unstructured":"Clark JB, Bates TE, Boakye P, Kuimov A, Land JM (1996) Investigation mitochondrial defects in brain and skeletal muscle. In: Turner AJ, Bachelor (eds) In a practical approach to the investigation of metabolic disease. IRL Press at Oxford University Press, Oxford. pp 151\u2013174"},{"key":"9222_CR50","doi-asserted-by":"crossref","first-page":"12753","DOI":"10.1074\/jbc.273.21.12753","volume":"273","author":"GP Davey","year":"1998","unstructured":"Davey GP, Peuchen S, Clark JB (1998) Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration. J Biol Chem 273:12753\u201312757","journal-title":"J Biol Chem"},{"issue":"Suppl","key":"9222_CR51","first-page":"S113","volume":"121","author":"PE Steele","year":"2004","unstructured":"Steele PE, Tang PH, DeGrauw AJ, Miles MV (2004) Clinical laboratory monitoring of coenzyme Q10 use in neurologic and muscular diseases. Am J Clin Pathol 121(Suppl):S113\u2013S120","journal-title":"Am J Clin Pathol"},{"key":"9222_CR52","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1089\/jmf.2005.8.397","volume":"8","author":"U Ullmann","year":"2005","unstructured":"Ullmann U, Metzner J, Schulz C, et al (2005) A new Coenzyme Q10 tablet-grade formulation (all-Q) is bioequivalent to Q-Gel and both have better bioavailability properties than Q-SorB. J Med Food 8:397\u2013399","journal-title":"J Med Food"},{"key":"9222_CR53","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/10715760600617843","volume":"40","author":"HN Bhagavan","year":"2006","unstructured":"Bhagavan HN, Chopra RK (2006) Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res 40:445\u2013453","journal-title":"Free Radic Res"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-006-9222-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-006-9222-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-006-9222-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T00:01:27Z","timestamp":1628294487000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-006-9222-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,21]]},"references-count":53,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2007,3,22]]}},"alternative-id":["9222"],"URL":"https:\/\/doi.org\/10.1007\/s11064-006-9222-8","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,21]]}}}